An updated patent review of AKT inhibitors (2020–present)
L Li, Y Guo, Y Lu, Y Xu, Y Lu, X Zhu… - Expert Opinion on …, 2023 - Taylor & Francis
ABSTRACT Introduction Protein kinase B (Akt), an essential protein in the PI3K/Akt/mTOR
signaling pathway, plays a crucial role in tumor progression. Over the past two years …
signaling pathway, plays a crucial role in tumor progression. Over the past two years …
An updated patent review of Akt inhibitors (2016-present)
Introduction: Akt is a widely known serine threonine kinase involved in a series of critical
cellular pathways like cell survival and proliferation. With the development of small-molecule …
cellular pathways like cell survival and proliferation. With the development of small-molecule …
A systematic molecular and pharmacologic evaluation of AKT inhibitors reveals new insight into their biological activity
E Kostaras, T Kaserer, G Lazaro, SF Heuss… - British Journal of …, 2020 - nature.com
Background AKT, a critical effector of the phosphoinositide 3-kinase (PI3K) signalling
cascade, is an intensely pursued therapeutic target in oncology. Two distinct classes of AKT …
cascade, is an intensely pursued therapeutic target in oncology. Two distinct classes of AKT …
Akt inhibitors in clinical development for the treatment of cancer
SK Pal, K Reckamp, H Yu, RA Figlin - Expert opinion on …, 2010 - Taylor & Francis
Importance of the field: The evolution of targeted therapies is dependent upon identification
of cellular moieties that can be pharmacologically modulated. As one such example, the …
of cellular moieties that can be pharmacologically modulated. As one such example, the …
Inhibition of Akt with small molecules and biologics: historical perspective and current status of the patent landscape
ME Mattmann, SL Stoops… - Expert opinion on …, 2011 - Taylor & Francis
Introduction: Akt plays a pivotal role in cell survival and proliferation through a number of
downstream effectors; unregulated activation of the PI3K/PTEN/Akt pathway is a prominent …
downstream effectors; unregulated activation of the PI3K/PTEN/Akt pathway is a prominent …
Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use
GM Nitulescu, D Margina… - International …, 2016 - spandidos-publications.com
Targeted cancer therapies are used to inhibit the growth, progression, and metastasis of the
tumor by interfering with specific molecular targets and are currently the focus of anticancer …
tumor by interfering with specific molecular targets and are currently the focus of anticancer …
Inhibitors of Akt activity
MA Seefeld, MB Rouse, DA Heerding - US Patent 8,273,782, 2012 - Google Patents
First worldwide family litigation filed litigation Critical https://patents. darts-ip. com/? family=
39682107&utm_source= google_patent&utm_medium= platform_link&utm_campaign …
39682107&utm_source= google_patent&utm_medium= platform_link&utm_campaign …
Inhibitors of Akt activity
MA Seefeld, MB Rouse, DA Heerding - US Patent 8,410,158, 2013 - Google Patents
First worldwide family litigation filed litigation Critical https://patents. darts-ip. com/? family=
39682107&utm_source= google_patent&utm_medium= platform_link&utm_campaign …
39682107&utm_source= google_patent&utm_medium= platform_link&utm_campaign …
Discovery of Inter-Domain Stabilizers A Novel Assay System for Allosteric Akt Inhibitors
In addition to the catalytically active kinase domain, most kinases feature regulatory domains
that govern their activity. Modulating and interfering with these interdomain interactions …
that govern their activity. Modulating and interfering with these interdomain interactions …
Recent advance of Akt inhibitors in clinical trials
K Guo, W Tang, H Zhuo, G Zhao - ChemistrySelect, 2019 - Wiley Online Library
The serine/threonine kinase Akt, also known as protein kinase B (PKB), exerts a critical role
in the phosphoinositide 3‐kinase (PI3 K)‐Akt signaling pathway that involves in cell growth …
in the phosphoinositide 3‐kinase (PI3 K)‐Akt signaling pathway that involves in cell growth …